Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Second-Line Therapy for Metastatic CRC

January 30th 2015

Postoperative Therapy for Metastatic CRC

January 30th 2015

Treatment Selection in RAS Wild-Type mCRC

January 30th 2015

Communication Strategies for Newly Diagnosed mCRC

January 30th 2015

Expanded RAS Testing Required in CRC

January 30th 2015

Exercise and Lifestyle Factors in Patients with mCRC

January 30th 2015

Adjuvant Therapy in Stage II Colon Cancer

January 30th 2015

Molecular Testing in Colorectal Cancer

January 30th 2015

Colorectal Cancer Screening and Prevention

January 30th 2015

Emerging Therapies for Pancreatic Cancer

January 30th 2015

First- and Second-Line Treatments for Advanced Pancreatic Cancer

January 30th 2015

Neoadjuvant Therapy for Locally Advanced Pancreatic Cancer

January 30th 2015

Use of Systemic Therapy for Resectable Pancreatic Cancer

January 30th 2015

Screening for Pancreatic Cancer in High-Risk Individuals

January 30th 2015

Molecular and Biologic Characteristics of Pancreatic Cancer

January 30th 2015

Questions Remain Regarding Combinations and Sequencing in pNETs

January 26th 2015

To gain insight into the unanswered questions surrounding the treatment of pNETs, OncLive interviewed Pamela L. Kunz, MD, Assistant Professor of Medicine/Oncology at Stanford University.

Multitargeted Drug Slows CRC as Third-Line Therapy

January 21st 2015

Treatment with a multitargeted tyrosine kinase inhibitor led to a small but statistically significant improvement in progression-free survival (PFS) in patients with advanced, previously treated metastatic colorectal cancer.

Dr. Muro on Pembrolizumab for Gastric Cancer

January 19th 2015

Kei Muro, MD, of the Aichi Cancer Center Hospital in Nagoya, Japan, discusses updated findings from the KEYNOTE-012 study, which looked at pembrolizumab for the treatment if several types of cancer.

Dr. Laura Dawson on HCC Challenges

January 19th 2015

Laura Dawson, MD, Princess Margaret Hospital, University of Toronto, talks about the challenges in treating hepatocellular carcinoma (HCC).

Monocyte-Targeting Agent Active in Locally Advanced Pancreatic Cancer

January 18th 2015

Almost half of patients with borderline resectable or locally advanced pancreatic cancer had objective responses to treatment with an investigational chemokine receptor antagonist.

x